Mercer Global Advisors Inc Cerus Corp Transaction History

Mercer Global Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$4.5 - $7.02 $126,922 - $197,999	-28,205 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$2.87 - $5.49 $1,297 - $2,481	452 Added 1.63%	28,205 $131,000
Q4 2019 Feb 13, 2020	BUY	$3.84 - $4.86 $17,514 - $22,166	4,561 Added 19.67%	27,753 $117,000
Q3 2019 Nov 12, 2019	BUY	$4.86 - $6.05 $6,449 - $8,028	1,327 Added 6.07%	23,192 $119,000
Q2 2019 Aug 14, 2019	BUY	$4.51 - $6.6 $1,339 - $1,960	297 Added 1.38%	21,865 $123,000
Q1 2019 Apr 23, 2019	BUY	$5.16 - $6.85 $111,290 - $147,740	21,568 New	21,568 $134,000

160

144M

22.5K

23.6K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $328M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.